QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
$1.77
+6.0%
$1.64
$0.52
$2.17
$120.66M0.95360,454 shs567,410 shs
HEXO Corp. stock logo
HEXO
HEXO
$0.71
+2.5%
$0.87
$0.66
$3.84
$31.24M1.35880,508 shs305,500 shs
Leaf Group Ltd. stock logo
LEAF
Leaf Group
$8.49
$8.47
$2.48
$9.50
$305.91M2.13959,348 shsN/A
Meredith Co. stock logo
MDP
Meredith
$58.78
$18.00
$59.16
$2.70B2.07552,848 shs3.36 million shs
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
-4.57%-14.80%+9.87%+56.07%+217.07%
HEXO Corp. stock logo
HEXO
HEXO
0.00%0.00%0.00%0.00%-40.83%
Leaf Group Ltd. stock logo
LEAF
Leaf Group
0.00%0.00%0.00%0.00%0.00%
Meredith Co. stock logo
MDP
Meredith
0.00%0.00%0.00%0.00%-16.22%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
1.243 of 5 stars
3.53.00.00.01.10.00.6
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/AN/AN/AN/AN/A
Leaf Group Ltd. stock logo
LEAF
Leaf Group
N/AN/AN/AN/AN/AN/AN/AN/A
Meredith Co. stock logo
MDP
Meredith
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
3.00
Buy$3.0069.49% Upside
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/A
Leaf Group Ltd. stock logo
LEAF
Leaf Group
N/AN/AN/AN/A
Meredith Co. stock logo
MDP
Meredith
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
$60K2,011.02N/AN/A$0.32 per share5.53
HEXO Corp. stock logo
HEXO
HEXO
$146.20M0.21N/AN/A$2.44 per share0.29
Leaf Group Ltd. stock logo
LEAF
Leaf Group
$212.06M1.44$0.02 per share400.34$2.19 per share3.88
Meredith Co. stock logo
MDP
Meredith
$2.98B0.00N/A5.68$14.27 per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
-$20.84M-$0.33N/AN/AN/AN/A-76.18%-62.52%5/20/2024 (Estimated)
HEXO Corp. stock logo
HEXO
HEXO
-$845.90M-$5.21N/AN/AN/A-235.33%-74.04%-32.51%N/A
Leaf Group Ltd. stock logo
LEAF
Leaf Group
-$8.86MN/AN/AN/A-1.94%-7.40%-3.79%N/A
Meredith Co. stock logo
MDP
Meredith
$306.60M$5.9010.01N/AN/A9.66%41.72%4.92%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
N/AN/AN/AN/AN/A
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/AN/A
Leaf Group Ltd. stock logo
LEAF
Leaf Group
N/AN/AN/AN/AN/A
Meredith Co. stock logo
MDP
Meredith
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
0.01
4.36
4.36
HEXO Corp. stock logo
HEXO
HEXO
0.01
0.41
0.24
Leaf Group Ltd. stock logo
LEAF
Leaf Group
0.01
1.65
1.65
Meredith Co. stock logo
MDP
Meredith
4.03
1.39
1.36

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
12.49%
HEXO Corp. stock logo
HEXO
HEXO
7.78%
Leaf Group Ltd. stock logo
LEAF
Leaf Group
70.80%
Meredith Co. stock logo
MDP
Meredith
78.23%

Insider Ownership

CompanyInsider Ownership
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
5.25%
HEXO Corp. stock logo
HEXO
HEXO
4.69%
Leaf Group Ltd. stock logo
LEAF
Leaf Group
11.40%
Meredith Co. stock logo
MDP
Meredith
9.79%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Cardiol Therapeutics Inc. stock logo
CRDL
Cardiol Therapeutics
N/A68.17 million64.59 millionNot Optionable
HEXO Corp. stock logo
HEXO
HEXO
1,27744.00 million41.93 millionOptionable
Leaf Group Ltd. stock logo
LEAF
Leaf Group
36036.03 millionN/AOptionable
Meredith Co. stock logo
MDP
Meredith
5,33045.78 million41.30 millionOptionable

MDP, HEXO, LEAF, and CRDL Headlines

SourceHeadline
Legendary Investor Meredith Whitney Just Issued a Big Housing Market WarningLegendary Investor Meredith Whitney Just Issued a Big Housing Market Warning
investorplace.com - November 8 at 3:06 PM
Medexus Pharmaceuticals Inc. (TSE:MDP): Are Analysts Optimistic?Medexus Pharmaceuticals Inc. (TSE:MDP): Are Analysts Optimistic?
finance.yahoo.com - January 31 at 8:41 AM
Medexus Pharmaceuticals Second Quarter 2023 Earnings: Beats ExpectationsMedexus Pharmaceuticals Second Quarter 2023 Earnings: Beats Expectations
finance.yahoo.com - November 11 at 6:07 AM
Medexus Announces Strongest Quarter in Company History with Fiscal Q2 2023 Revenue of US$27.7 Million, a 55% Increase Over Fiscal Q2 2022Medexus Announces Strongest Quarter in Company History with Fiscal Q2 2023 Revenue of US$27.7 Million, a 55% Increase Over Fiscal Q2 2022
finance.yahoo.com - November 8 at 5:35 PM
Medexus Pharmaceuticals Inc (MDP) NPVMedexus Pharmaceuticals Inc (MDP) NPV
hl.co.uk - November 6 at 12:02 AM
Medexus Announces Preliminary Revenue Results for Second Fiscal Quarter 2023Medexus Announces Preliminary Revenue Results for Second Fiscal Quarter 2023
finance.yahoo.com - October 6 at 8:06 AM
Medexus Provides Update on Treosulfan NDA Resubmission and Provides Business UpdateMedexus Provides Update on Treosulfan NDA Resubmission and Provides Business Update
finance.yahoo.com - September 19 at 8:44 AM
Medexus Holds Annual Meeting of Shareholders and Announces Election of Board of DirectorsMedexus Holds Annual Meeting of Shareholders and Announces Election of Board of Directors
finance.yahoo.com - September 15 at 7:02 PM
Medexus Pharma MDP is in the bottom 25 performing stocks year-to-date on the Toronto Stock ExchangeMedexus Pharma MDP is in the bottom 25 performing stocks year-to-date on the Toronto Stock Exchange
theglobeandmail.com - August 17 at 6:48 PM
Medexus Pharmaceuticals Inc. (MEDXF) CEO Ken dEntremont on Q1 2023 Results - Earnings Call TranscriptMedexus Pharmaceuticals Inc. (MEDXF) CEO Ken d'Entremont on Q1 2023 Results - Earnings Call Transcript
seekingalpha.com - August 9 at 11:29 AM
Medexus Announces Record Fiscal Q1 2023 Revenue of US$23.0 Million, a 33% Increase versus Fiscal Q1 2022Medexus Announces Record Fiscal Q1 2023 Revenue of US$23.0 Million, a 33% Increase versus Fiscal Q1 2022
finance.yahoo.com - August 8 at 8:26 PM
Meredith Corporation Announces Winners of Good Impressions ProgramMeredith Corporation Announces Winners of Good Impressions Program
finance.yahoo.com - November 23 at 12:48 PM
What Does Merediths Debt Look Like?What Does Meredith's Debt Look Like?
benzinga.com - October 9 at 10:11 AM
A Stock Analysis Of Meredith Corporation’s (MDP)A Stock Analysis Of Meredith Corporation’s (MDP)
stocksregister.com - October 9 at 10:11 AM
Why Meredith Corporation (NYSE: MDP) Should Be Included On Your WatchlistWhy Meredith Corporation (NYSE: MDP) Should Be Included On Your Watchlist
marketingsentinel.com - October 9 at 10:11 AM
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Meredith Corporation (NYSE - MDP)SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Meredith Corporation (NYSE - MDP)
finance.yahoo.com - October 8 at 1:39 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Cardiol Therapeutics logo

Cardiol Therapeutics

NASDAQ:CRDL
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx for patients hospitalized with COVID-19, as well as for the treatment of recurrent pericarditis and acute myocarditis. The company is also developing subcutaneous formulation of CardiolRx for the treatment of fibrosis and inflammation in the heart that is related with the development and progression of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
HEXO logo

HEXO

NYSE:HEXO
HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. It has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada. As of June 22, 2023, HEXO Corp. operates as a subsidiary of Tilray Brands, Inc.
Leaf Group logo

Leaf Group

NYSE:LEAF
Leaf Group Ltd., together with its subsidiaries, operates as a diversified consumer internet company worldwide. It operates in two segments, Marketplaces and Media. The Marketplaces segment offers Society6.com, which provides artists with an online commerce platform to feature and sell their original art and designs on consumer products in the wall art, home décor, and tech and apparel accessories categories. It also provides SaatchiArt.com and its related art fair event brand, which is an online art gallery where a global community of artists exhibit and sell their original artwork directly to consumers. The Media segment offers Well+Good, a health and wellness media brand that offers journalistic approach to content; and Livestrong.com, a destination and action-oriented community, as well as mobile applications, such as MyPlate that monitor users' health, fitness, and life achievements. This segment also provides Hunker, a home design media site for enabling first-time homeowners enhance their homes with practical solutions, home tours, and design advice for people; and Only In Your State, a US-focused local attractions and review site, which highlights small businesses, hidden gems, and natural wonders for the audience. In addition, this segment offers content creation, traffic source, mobile application, and monetization services; and develops partner sites. It sells its products through wholesale channels to trade and hospitality clients, as well as through retail distribution partners. The company was formerly known as Demand Media, Inc. and changed its name to Leaf Group Ltd. in November 2016. Leaf Group Ltd. was incorporated in 2006 and is headquartered in Santa Monica, California.
Meredith logo

Meredith

NYSE:MDP
Meredith Corp. engages in television broadcasting and magazine advertising business. It operates through the Local Media and National Media business segments. The Local Media segment includes television stations and offers websites, mobile-optimized websites, and mobile applications. The National Media segment consists of national consumer media brands delivered via multiple media platforms including print magazines and digital and mobile media, brand licensing activities, database-related activities, and business-to-business marketing products and services. The company was founded by Edwin Thomas Meredith in 1902 and is headquartered in Des Moines, IA.